Is a complete TPEX/6539 research report available?

No complete published report is available for tpex/6539 (TPEX/6539) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/6539 stock profile: metrics, valuation and analysis

Market cap	999.5M
Revenue (ttm)	795.2M
Net income (ttm)	76.6M
EPS (ttm)	NT$3.15
Shares out	24.3M
P/E (trailing)	13.0x
Dividend	NT$2.00 (4.87%)
Volume	510
Beta	0.07

All TPEX/6539 indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

TWD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	316
Employees Change	10%
Employees Change Percent	3.27
Enterprise value	TWD 683.6M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.61
Isin	TW0006539000
Last refreshed	2026-09-13
Market cap	TWD 999.5M
Price	TWD 41.05
Price currency	TWD
Rev Per Employee	2,439,239.26x
Sector	Healthcare
Sector PE	86.1
Sector PE Fwd	26.83
Sic	2844
Symbol	tpex/6539
Website	https://www.dvbiomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.67%
EV Earnings	8.92x
EV/EBIT	9.21x
EV/EBITDA	6.5x
EV/FCF	13.57x
EV/Sales	0.86x
FCF yield	5.04%
P/B ratio	1.82x
P/E ratio	12.99x
P/S ratio	1.26x
PE Ratio10 Y	24.34x
PE Ratio3 Y	38.47x
PE Ratio5 Y	27.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.33%
EBITDA Margin	10.91%
FCF margin	6.34%
Gross margin	72.53%
Gross Profit	TWD 576.7M
Gross Profit Growth	12.69%
Gross Profit Growth Q	3.62%
Gross Profit Growth3 Y	-10.07%
Gross Profit Growth5 Y	-10.37%
Net Income	TWD 76.6M
Net Income Growth	46.26%
Net Income Growth Qo Q	199.79%
Net Income Growth Quarters	4%
Net Income Growth Years	0%
Net Income Growth3 Y	-33.33%
Net Income Growth5 Y	-21.49%
Pretax Margin	11.78%
Profit Margin	9.63%
Profit Per Employee	TWD 235,018
Profitable Quarters	TWD 4
Profitable Years	7
ROA	6.71
Roa5y	8.97
ROCE	12.89
ROE	14.97
Roe5y	17.69
ROIC	26.09
Roic5y	26.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-13.82%
Cagr1y	-23.96%
Cagr3y	-33.23%
Cagr5y	-19.12%
Div CAGR10	-8.41%
Div CAGR3	-49.3%
Div CAGR5	-34.47%
EPS Growth	54.4
EPS Growth Qo Q	202.1
EPS Growth Quarters	4
EPS Growth Years	0
EPS Growth3 Y	-33.26
EPS Growth5 Y	-21.31
FCF Growth	-61.74%
FCF Growth Q	166.99%
FCF Growth Qo Q	100.8%
FCF Growth3 Y	-37.04%
FCF Growth5 Y	-36.47%
OCF Growth	-51.06%
OCF Growth Q	54.91%
OCF Growth Qo Q	4.77%
OCF Growth10 Y	-6.87%
OCF Growth3 Y	-37.11%
OCF Growth5 Y	-33.98%
Revenue Growth	11.59x
Revenue Growth Q	0.26x
Revenue Growth Qo Q	-4.35x
Revenue Growth Years	1x
Revenue Growth3 Y	-14.5x
Revenue Growth5 Y	-15.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 1.15
Assets	TWD 720.2M
Cash	TWD 352.6M
Current Assets	TWD 544.2M
Current Liabilities	TWD 144.6M
Debt	TWD 36.7M
Debt EBITDA	TWD 0.35
Debt Equity	TWD 0.07
Debt FCF	TWD 0.73
Equity	TWD 549.6M
Interest Coverage	67.16
Liabilities	TWD 170.6M
Long Term Assets	TWD 176M
Long Term Liabilities	TWD 26M
Net Cash	TWD 315.9M
Net Cash By Market Cap	TWD 31.61
Net Cash Growth	17.35%
Net Debt EBITDA	TWD -3.64
Net Debt Equity	TWD -0.57
Net Debt FCF	TWD -6.27
Tangible Book Value	TWD 547.6M
Tangible Book Value Per Share	TWD 22.49
WACC	4.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.76
Inventory Turnover	1.86
Net Working Capital	TWD 61.9M
Quick ratio	2.75
Working Capital	TWD 399.6M
Working Capital Turnover	TWD 2.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.02%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	TWD 2
Dividend Years	12
Dividend Yield	4.87%
Ex Div Date	2026-08-27
Last Dividend	TWD 1
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-77.4%
1Y total return	-23.95%
200-day SMA	49.72
3Y total return	-70.24%
50-day SMA	41.3
50-day SMA vs 200-day SMA	50under200
5Y total return	-65.38%
All Time High	335.7
All Time High Change	-87.77%
All Time High Date	2016-06-07
All Time Low	38.3
All Time Low Change	7.18%
All Time Low Date	2026-08-10
ATR	0.86
Beta	0.07
Beta1y	0.29
Beta2y	0.26
Ch YTD	-30.42
High	41.05
High52	60.8
High52 Date	2025-12-30
High52ch	-32.48%
Low	39
Low52	38.3
Low52 Date	2026-08-10
Low52ch	7.18%
Ma50ch	-0.61%
Price vs 200-day SMA	-17.44%
RSI	49.58
RSI Monthly	29.94
RSI Weekly	34.49
Sharpe ratio	-1.02x
Sharpe Ratio3y	-0.7x
Sharpe Ratio5y	-0.38x
Sortino ratio	-1.15
Sortino Ratio3y	-0.74
Sortino Ratio5y	-0.36
Total Return	4.85%
Tr YTD	-27.68
Tr1m	4.32%
Tr3m	6.93%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,582,929%
Net Borrowing	-17,867,000
Shares Insiders	15.88%
Shares Out	24,349,000
Shares Qo Q	0.02%
Shares Yo Y	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,055.5x
Bv Per Share	22.57
CAPEX	TWD -19.8M
Ch10y	-85.68
Ch1m	1.86
Ch1y	-26.83
Ch3m	2.88
Ch3y	-72.99
Ch5y	-73.27
Ch6m	-24.26
Change	0%
Change From Open	5.26
Close	41.05
Days Gap	-4.99
Depreciation Amortization	12,516,000
Dollar Volume	20,935.5
Earnings Date	2026-11-13
EBIT	TWD 74.2M
EBITDA	TWD 86.7M
EPS	TWD 3.15
F Score	6
FCF	TWD 50.4M
FCF EV Yield	7.37x
FCF Per Share	TWD 2.07
Financing CF	-17,367,000
Fiscal Year End	December
Founded	2,011
Graham Number	39.96611
Graham Upside	-2.64
Income Tax	TWD 16.7M
Investing CF	-67,877,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2026-06-30
Last Split Date	2025-08-28
Last Split Type	Forward
Lynch Fair Value	TWD 15.73
Lynch Upside	-61.69
Ma150	47.71
Ma150ch	-13.96%
Ma20	41.16
Ma20ch	-0.27%
Net CF	-16,181,000
Next Earnings Date	2026-11-13
Open	39
P FCF Ratio	19.84
P OCF Ratio	14.23
Payment Date	2026-09-16
Position In Range	100
Ppne	62,775,000
Price Date	2026-09-11
Price EBITDA	TWD 11.52
Ptbv Ratio	1.83
Relative Volume	0.31x
Revenue	795,192,000x
Tax By Revenue	2.1x
Tax Rate	17.84%
Tr6m	-21.28%
Volume	510
Z Score	7.32

TPEX/6539 (TPEX/6539)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6539

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6539 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6539

Frequently asked questions